Correlation Between Tonix Pharmaceuticals and Palisade Bio
Can any of the company-specific risk be diversified away by investing in both Tonix Pharmaceuticals and Palisade Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tonix Pharmaceuticals and Palisade Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tonix Pharmaceuticals Holding and Palisade Bio, you can compare the effects of market volatilities on Tonix Pharmaceuticals and Palisade Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tonix Pharmaceuticals with a short position of Palisade Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tonix Pharmaceuticals and Palisade Bio.
Diversification Opportunities for Tonix Pharmaceuticals and Palisade Bio
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Tonix and Palisade is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Tonix Pharmaceuticals Holding and Palisade Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Palisade Bio and Tonix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tonix Pharmaceuticals Holding are associated (or correlated) with Palisade Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Palisade Bio has no effect on the direction of Tonix Pharmaceuticals i.e., Tonix Pharmaceuticals and Palisade Bio go up and down completely randomly.
Pair Corralation between Tonix Pharmaceuticals and Palisade Bio
Given the investment horizon of 90 days Tonix Pharmaceuticals Holding is expected to generate 2.6 times more return on investment than Palisade Bio. However, Tonix Pharmaceuticals is 2.6 times more volatile than Palisade Bio. It trades about 0.02 of its potential returns per unit of risk. Palisade Bio is currently generating about -0.22 per unit of risk. If you would invest 3,601 in Tonix Pharmaceuticals Holding on December 29, 2024 and sell it today you would lose (1,584) from holding Tonix Pharmaceuticals Holding or give up 43.99% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Tonix Pharmaceuticals Holding vs. Palisade Bio
Performance |
Timeline |
Tonix Pharmaceuticals |
Palisade Bio |
Tonix Pharmaceuticals and Palisade Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tonix Pharmaceuticals and Palisade Bio
The main advantage of trading using opposite Tonix Pharmaceuticals and Palisade Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tonix Pharmaceuticals position performs unexpectedly, Palisade Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Palisade Bio will offset losses from the drop in Palisade Bio's long position.Tonix Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Tonix Pharmaceuticals vs. Palisade Bio | Tonix Pharmaceuticals vs. iBio, Common Stock | Tonix Pharmaceuticals vs. Jaguar Animal Health |
Palisade Bio vs. Zura Bio Limited | Palisade Bio vs. Immix Biopharma | Palisade Bio vs. Enveric Biosciences | Palisade Bio vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Money Managers Screen money managers from public funds and ETFs managed around the world |